BioLineRx to Report First Quarter 2025 Results on May 27, 2025
Provided By PR Newswire
Last update: May 20, 2025
Management to Hold Conference Call at 8:30 a.m. EDT
TEL AVIV, Israel, May 20, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its unaudited financial results for the quarter ended March 31, 2025 on Tuesday, May 27, 2025, before the U.S. markets open.
Read more at prnewswire.com
